“Everything went well with new format for signing in. Thrilled to be back with Dr. Thanks.”
Retinitis Pigmentosa: Understanding Inherited Retinal Disease
Who Is at Risk for Retinitis Pigmentosa?
RP is primarily a genetic condition passed from parents to children through DNA. Because more than 100 different genes have been linked to RP, the way the disease is inherited can vary considerably from one family to another. Understanding the inheritance pattern helps patients and families assess their own risk.
In autosomal dominant RP, only one copy of the mutated gene is needed to cause the disease. A child has approximately a 1 in 2 chance of inheriting the condition if one parent carries the mutation. This pattern accounts for a significant portion of RP cases.
Autosomal recessive RP requires both parents to carry a copy of the mutated gene. Each child then has a 1 in 4 chance of being affected. Parents who each carry one copy of the mutation typically show no symptoms themselves, which is why this form of RP can appear unexpectedly in families with no prior history of the condition.
X-linked RP is carried on the X chromosome and primarily affects males. Women who carry the mutation often have mild or no symptoms but can pass the condition to their sons. X-linked forms of RP tend to progress more rapidly, particularly in males, and are associated with more severe vision loss at earlier ages.
In some cases, RP occurs as part of a broader genetic syndrome affecting other organs. Usher syndrome is the most common example, causing both RP-related vision loss and hearing loss. Bardet-Biedl syndrome involves RP along with features such as obesity and kidney problems. When parents are biological relatives, the risk for autosomal recessive RP is higher because both parents are more likely to carry the same mutation. Genetic testing can identify whether RP is part of a larger syndrome.
Symptoms of Retinitis Pigmentosa
The symptoms of RP follow a recognizable pattern for most patients, beginning with night vision problems and gradually progressing to narrowing peripheral vision and eventual central vision loss. The exact pace and severity vary widely between individuals, even within the same family.
Difficulty seeing in dim light or darkness is usually the earliest symptom of RP, often appearing in childhood or adolescence. This is called night blindness, or nyctalopia. A person may have trouble navigating a dark room, struggle when moving from a bright outdoor space to a dimly lit interior, or find nighttime driving increasingly difficult.
As rod cells continue to deteriorate, side vision progressively shrinks. People with RP may bump into objects that are not directly in front of them or fail to notice movement at the edges of their visual field. Over time, the visual field narrows to what is often described as tunnel vision, where only a small central area remains.
In later stages, cone cells also become affected. This leads to difficulty reading, trouble recognizing faces, and changes in color perception. Some individuals retain useful central vision well into adulthood, while others experience earlier and faster decline. The rate of change depends largely on the specific gene mutation involved.
Children may not recognize or report vision problems on their own. Parents should watch for signs such as tripping or bumping into furniture in low light, reluctance to go outdoors after dark, or difficulty keeping up with peers in dimly lit spaces. If any of these patterns are present, an evaluation by a retina specialist is important, especially when there is a family history of RP.
Diagnosing Retinitis Pigmentosa
An accurate diagnosis of RP requires a combination of clinical examination, specialized testing, and in many cases genetic analysis. Our team uses advanced diagnostic tools to assess retinal function and structure in detail, allowing us to confirm the diagnosis and plan appropriate care.
The diagnostic process begins with a comprehensive dilated eye exam. Drops are used to widen the pupil, giving the retina specialist a clear view of the retina. The characteristic pigment deposits, narrowed vessels, and pale optic disc appearance seen in RP are visible during this exam and provide important initial evidence of the condition.
Electroretinography (ERG) is one of the most important tests for diagnosing RP. It measures the electrical response of the retina to flashes of light. In people with RP, the signals from rod and cone cells are reduced or absent. ERG can detect retinal dysfunction even before significant vision loss has occurred, making it a valuable tool for identifying at-risk family members before symptoms begin.
Visual field testing maps which areas of a patient's vision are still functioning and helps track the pace of peripheral vision loss over time. Optical coherence tomography (OCT), a non-invasive imaging scan, produces detailed cross-sectional images of the retinal layers and can show structural thinning and other changes associated with RP. We also use wide-field imaging and fundus photography to document the retina's appearance at each visit, allowing us to compare images over time and detect subtle changes early.
Genetic testing has become an essential part of diagnosing and managing RP. A blood or saliva sample is analyzed to identify the specific gene mutation responsible for the disease. Knowing the exact mutation can confirm the diagnosis, clarify the inheritance pattern, guide family planning discussions, and determine whether a patient may be eligible for gene therapy or clinical trials. Even when no targeted treatment is currently available for a specific mutation, having that genetic information on file is valuable as new therapies continue to emerge.
Treatment and Management Options
There is currently no treatment that can fully reverse the vision loss caused by RP, but several approaches can slow progression, manage complications, and support quality of life. Research is advancing rapidly, and our team stays closely informed about emerging therapies so we can guide patients toward the options that are right for them.
Luxturna (voretigene neparvovec) is the first FDA-approved gene therapy for an inherited retinal disease. It is designed for patients whose RP is caused by mutations in both copies of the RPE65 gene, which represents a small percentage of all RP cases. The therapy delivers a functional copy of the RPE65 gene into the retina through a surgical procedure and has been shown to improve the ability to navigate in low-light conditions. Genetic testing is required to confirm RPE65 mutation status before this therapy can be considered.
Some research has suggested that vitamin A palmitate may slow retinal degeneration in certain RP patients, but high-dose vitamin A can be harmful, particularly to the liver, and is not appropriate for everyone. It should never be started without guidance from a retina specialist. Pregnant women or those planning pregnancy should not take high-dose vitamin A. Protecting overall retinal health through a balanced diet rich in leafy greens and omega-3 fatty acids, combined with UV-protective sunglasses outdoors, supports general eye wellness.
People with RP are at higher risk for certain secondary eye conditions that can further reduce vision. Cataracts, which are a clouding of the eye's natural lens, are common in RP and can be treated with surgery. Cystoid macular edema, which is swelling in the central retina, can also develop and may respond to treatment with carbonic anhydrase inhibitor medications. Identifying and treating these complications promptly can help preserve functional vision for longer.
Low vision rehabilitation helps people with RP maximize their remaining vision and adapt to daily life. Magnifying glasses, telescopic lenses, high-contrast displays, and text-to-speech software can assist with reading and other tasks. Orientation and mobility training helps individuals move safely through their environment. Our team can connect patients with low vision specialists and rehabilitation services tailored to their current level of vision.
Living With Retinitis Pigmentosa
A diagnosis of RP affects far more than eyesight. Planning ahead, staying informed about research, and building a strong support network all play an important role in navigating life with a progressive retinal condition.
It is completely normal to feel grief, anxiety, or uncertainty after a diagnosis of RP. These responses reflect the weight of a life-changing condition, and they deserve attention. Connecting with support groups, counseling services, and organizations dedicated to inherited retinal diseases can provide practical guidance and emotional comfort. Hearing from others who share a similar experience can be genuinely helpful.
Because RP is progressive, developing adaptive skills while vision is still relatively strong can ease future transitions. This may include learning to use assistive technology, making safety modifications at home, or preparing transportation alternatives for when driving becomes difficult. Working consistently with a retina specialist ensures that the care plan can be adjusted as vision changes over time.
Treatments for RP are being actively investigated on several fronts. Gene therapies targeting mutations such as the RPGR gene in X-linked RP are in advanced stages of clinical testing. Optogenetic approaches, which aim to restore light sensitivity to remaining retinal cells even after photoreceptors are gone, have shown early promise. These therapies are not yet approved outside of clinical trials, but a retina specialist can help determine whether a patient may be eligible to participate and provide guidance as new options become available.
Genetic counseling is recommended for individuals diagnosed with RP and for family members who may be at risk. A genetic counselor can explain what specific test results mean, help family members understand their personal risk level, and guide couples planning a family through the implications of their genetic findings. This kind of personalized guidance is an important part of managing RP comprehensively.
When to See a Retina Specialist
Knowing when to seek care, and how urgently, is important for anyone with RP or a family history of the condition. Regular monitoring is essential, but certain symptoms require immediate attention.
While RP itself progresses slowly, some symptoms require prompt evaluation right away. A sudden increase in floaters, new flashes of light, a shadow or curtain appearing across any part of your vision, or any sudden loss of vision should be treated as a medical emergency. These symptoms can indicate a retinal tear or detachment, which requires rapid treatment to prevent permanent vision loss. Contact a retina specialist immediately or go to the nearest emergency room if any of these occur.
Even when vision feels stable, regular visits with a retina specialist are essential. Monitoring with ERG, visual field testing, and OCT imaging allows our team to track retinal health over time and detect complications such as macular edema or cataracts at the earliest opportunity. At Atlantic Retina Center, we perform serial retinal photo comparisons at every visit, giving us a documented record of how the retina looks over time and helping us identify even subtle changes before they affect vision.
If RP is suspected because of symptoms or family history, a retina specialist can arrange genetic testing. Identifying the specific mutation is increasingly valuable as targeted therapies and clinical trials continue to expand. Even if no approved treatment exists for a particular mutation today, having genetic results on file positions patients to access emerging therapies and trials as they become available.
Frequently Asked Questions
These answers address common questions about RP that go beyond the basics, including practical guidance on next steps and when to act quickly.
Yes, and early detection has real value. Electroretinography can identify reduced retinal electrical activity before noticeable vision loss begins. Genetic testing can confirm a mutation in family members who carry the gene but have not yet developed symptoms. For someone with a known family history of RP, a baseline evaluation with ERG and retinal imaging is worthwhile even if their vision currently feels normal. This baseline allows future changes to be measured accurately and may open doors to clinical trial eligibility.
Not yet. Luxturna is the only currently FDA-approved gene therapy for an inherited retinal disease, and it applies only to the specific subset of RP caused by mutations in both copies of the RPE65 gene. This represents a small fraction of all RP cases. Multiple other gene therapies targeting different mutations are being tested in clinical trials and may become available in the coming years. Genetic testing is the essential first step to determine whether any available or upcoming therapy may apply to a specific patient.
The answer depends entirely on your inheritance pattern and specific mutation. If you have autosomal dominant RP, each child has roughly a 1 in 2 chance of inheriting the condition. If your RP is autosomal recessive and your partner does not carry the same mutation, the risk to children is much lower, but a genetic counselor should review your specific results to give accurate guidance. For X-linked RP, a carrier mother has approximately a 1 in 2 chance of passing the mutation to each son. These probabilities are general estimates, and a genetic counselor can provide personalized risk assessment based on your exact mutation and family situation.
While avoiding all light is not necessary or practical, protecting the eyes from excessive ultraviolet (UV) exposure is generally recommended. Wearing UV-blocking sunglasses outdoors reduces additional light-related stress on an already vulnerable retina. Glare can also be particularly uncomfortable for people with RP, so tinted or anti-glare lenses may improve comfort in bright conditions. Your retina specialist can offer specific guidance based on your stage of disease.
The appropriate monitoring schedule depends on the rate of your disease progression, any complications present, and whether you are being evaluated for a clinical trial or specific treatment. Many patients benefit from annual visits, while those with faster-progressing disease or active complications may need more frequent follow-up. The most important thing is not to wait for noticeable vision changes before scheduling care. Early detection of complications like macular edema or cataracts allows treatment to begin when it is most effective.
RP can occur without any known family history. This can happen when both parents silently carry a recessive mutation, when the condition arises from a new mutation in the affected individual, or when family history was simply never diagnosed or reported. A comprehensive examination including ERG and genetic testing can confirm whether RP is present regardless of family background. If symptoms such as night blindness or narrowing side vision are occurring, do not wait for a family connection to seek an evaluation.
Caring for Your Retinal Health on the Eastern Shore
Our fellowship-trained, board-certified retina specialists are dedicated exclusively to the retina, vitreous, and macula, which means every patient who walks through our doors receives focused, expert care at the highest level. Atlantic Retina Center offers advanced diagnostic imaging, genetic testing coordination, and ongoing monitoring designed specifically for inherited retinal conditions like RP. If you or a family member has symptoms, a diagnosis, or a family history of retinitis pigmentosa, we encourage you to schedule a consultation with our team so we can help you understand your options and protect your vision for as long as possible.